Canonical ingredient

Acetamide, 2,2-dichloro-N-[2-hydroxy- 1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-, [R-(R,R)]-

CHLORAMPHENICOL

49 linked products

Official identifiers

CAS 56-75-7 ChEBI CHEBI:17698 InChI InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1 InChIKey WIIZWVCIJKGZOK-RKDXNWHRSA-N KEGG_COMPOUND C00918 NHPID_ID 5097 SMILES O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl

Names and synonyms

Acetamide, 2,2-dichloro-N-[2-hydroxy- 1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-, [R-(R,R)]- (en)
chloramphenicol (en)
Chloramphénicol (fr)
[R-(R,R)]-2,2-Dichloro-N-[2-hydroxy-1-(hydroxyméthyl)-2-(4-nitrophényl)éthyl]acétamide (fr-CA)

Source-scoped chemical properties

Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.

canada dsl listing: listed; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl bioaccumulative: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl human health priority: High; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl inherently toxic aquatic: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets cepa categorization: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets environmental: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets human health: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl persistent: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl substance category: Organics; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03

Safety and technical documents

General references and manufacturer-specific SDS documents are kept separate.

0 document(s)

No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.

End-to-end traceability

Only links supported by an identified source are published. Missing evidence remains explicitly unknown.

Partial chain

Evidence still missing

Country or region of origin
Raw-material producer
Ingredient manufacturer
Distributor
Transformation steps

Documented origins

No origin has been proven yet by an explicit source.

Documented organizations

No organization has been proven yet by an explicit source.

Documented transformations

No transformation step has been proven yet by an explicit source.

Method: a company’s registration country is never used as evidence of a material’s origin.

Products containing this ingredient

CEBENICOL OPH LIQ 0.4%

CHLOR-100 (CHLORAMPHENICOL TABLETS)

CHLOR-1000 (CHLORAMPHENICOL TABLETS)

CHLOR-250 (CHLORAMPHENICOL TABLETS)

CHLOR-250 CAPSULE 250MG

250 · MG · CAP

CHLOR-500 (CHLORAMPHENICOL TABLETS)

CHLORALEAN DROPS

CHLORAMPHENICOL

CHLORAMPHENICOL

CHLORAMPHENICOL 1%

CHLORICOL ONT 1%

CHLOROMYCETIN OPH ONT 1%

CHLOROMYCETIN OPH SOLN 0.5%

CHLOROPTIC DPS 0.5%

CHLOROPTIC OPH ONT 1%

ELASE CHLOROMYCETIN ONT

KAROMYCIN PALMITATE 125 SUSP 25MG/ML

KAROMYCIN PALMITATE 250 SUSP 50MG/ML

4.2 · MG · ML

MINIMS CHLORAMPHENICOL 0.5%

NOVO-CHLOROCAP CAP 250MG

250 · MG · CAP

ODAN-CHLORAMPHENICOL

0.5 · MG · ML

ODAN-CHLORAMPHENICOL

OPHTANICOL 1% OPHTHALMIC OINTMENT

OPHTHO-CHLORAM LIQ 0.5%

PENTAMYCETIN LIQ 2.5MG/ML

2.5 · MG · ML

PENTAMYCETIN ONT 10MG/GM

PENTAMYCETIN OPHTHALMIC SOLUTION 0.5% - LIQ

PENTAMYCETIN/HC

PENTAMYCETIN/HC

PMS-CHLORAMPHENICOL OPHTHALMIC OINTMENT

PMS-CHLORAMPHENICOL OPHTHALMIC SOLN 0.5%

SOPAMYCETIN OPH ONT 0.2%

SOPAMYCETIN SOLN OTIQUE 5%

SOPAMYCETIN SOLUTION OPHTHALMIQUE 0.2%

SOPAMYCETIN/HC OINTMENT

SOPAMYCETIN/HC ONT

SOPAMYCETIN/HC SUSP

ZOOMYCETINE 100INJ 100MG/ML

100 · MG · ML